In the modern fast-paced world, digestive health issues have become increasingly common. Conditions like acidity, gastric ulcers, and Gastroesophageal Reflux Disease (GERD) affect millions of people, significantly impacting their quality of life. Finding a treatment that provides both immediate relief and long-term healing is crucial. This is where sucralfate with oxetacaine oral suspension enters the scene as a clinically proven, dual-action solution.
At RounTalk Pharma, we are committed to delivering high-quality healthcare solutions that address the root causes of gastrointestinal distress. Our specialized formulation, PANRON 0, is designed to provide rapid symptomatic relief while creating a protective environment for the stomach lining to heal. This comprehensive guide explores how sucralfate with oxetacaine oral suspension works and why PANRON 0 by RounTalk Pharma is a trusted name in digestive wellness.
Sucralfate with oxetacaine oral suspension is a therapeutic combination used primarily to treat and manage acid-related disorders of the upper gastrointestinal tract. It belongs to a category of medications known as cytoprotective agents and local anesthetics. Unlike simple antacids that merely neutralize stomach acid, this suspension provides a physical barrier and localized numbing effect.
PANRON 0, manufactured by RounTalk Pharma, represents a sophisticated approach to gastroenterology. The formulation is liquid, ensuring that the medication can coat the esophagus and stomach lining evenly. This makes sucralfate with oxetacaine oral suspension more effective than traditional tablets for patients suffering from active ulceration or severe inflammation where direct contact with the mucosa is necessary for healing.

The effectiveness of PANRON 0 lies in its unique dual-ingredient composition. Each dose of this suspension by RounTalk Pharma is carefully balanced to ensure maximum therapeutic efficacy.
Sucralfate is a sucrose sulfate-aluminum complex. When it enters the acidic environment of the stomach, it undergoes a transformation. It dissociates into aluminum and sucrose sulfate, forming a viscous, paste-like substance. This “sticky” substance has a strong affinity for proteins found in ulcerated tissue (exudates). It binds specifically to the site of an ulcer, creating a physical “bandage” that protects the raw tissue from gastric acid, pepsin, and bile salts. By shielding the wound, the sucralfate in sucralfate with oxetacaine oral suspension allows the body’s natural healing processes to occur uninterrupted.
Oxetacaine (also known as Oxethazaine) is a potent local anesthetic. What makes it unique is its ability to remain effective even in highly acidic environments, whereas most local anesthetics lose their potency when exposed to stomach acid. In the PANRON 0 formulation by RounTalk Pharma, oxetacaine provides rapid relief from the burning pain associated with ulcers and gastritis. It numbs the lining of the stomach and esophagus, providing the patient with almost immediate comfort while the sucralfate works on the underlying structural damage.
When combined in sucralfate with oxetacaine oral suspension, these two ingredients provide a “protect and soothe” strategy. While one ingredient numbs the pain, the other builds a fortress over the injury. RounTalk Pharma has optimized this ratio in PANRON 0 to ensure that patients don’t just feel better—they actually get better.
Using sucralfate with oxetacaine oral suspension offers several advantages over monotherapy or standard antacid treatments. Here are the primary benefits of the PANRON 0 formulation:
RounTalk Pharma recommends PANRON 0 for a variety of clinical conditions. The versatile nature of sucralfate with oxetacaine oral suspension makes it a staple in gastroenterology departments.
Whether caused by H. pylori infection or the overuse of NSAIDs (painkillers), ulcers are painful sores in the lining of the stomach or the first part of the small intestine. Sucralfate with oxetacaine oral suspension is specifically indicated for the short-term treatment of active ulcers and for maintenance therapy to prevent recurrence.
In GERD, stomach acid frequently flows back into the tube connecting your mouth and stomach (esophagus). This backwash (acid reflux) can irritate the lining of your esophagus. PANRON 0 provides a soothing coating that prevents this irritation and allows the esophageal mucosa to recover from “acid burns.”
Inflammation of the stomach lining (gastritis) or the esophagus (esophagitis) can cause chronic discomfort, bloating, and nausea. The anti-inflammatory and protective properties of the suspension produced by RounTalk Pharma help calm these inflammations effectively.
For patients in intensive care or those under extreme physiological stress, sucralfate with oxetacaine oral suspension is often used as a prophylactic measure to prevent the formation of “stress ulcers.”
When it comes to pharmaceutical care, the brand you trust matters. RounTalk Pharma has established itself as a leader in quality and reliability. Here is why PANRON 0 stands out:
To get the most benefit from sucralfate with oxetacaine oral suspension, it must be administered correctly.
While sucralfate with oxetacaine oral suspension is generally well-tolerated, some patients may experience mild side effects. RounTalk Pharma believes in patient education to ensure safe usage.
The most common side effect is constipation, as sucralfate contains aluminum. Other rare side effects might include:
To maintain the shelf-life and efficacy of sucralfate with oxetacaine oral suspension, follow these storage guidelines:

PANRON 0 is primarily used to treat stomach ulcers, duodenal ulcers, gastritis, and GERD by providing a protective coating and numbing pain.
It should be taken on an empty stomach, usually 1 hour before meals and at bedtime, as directed by your doctor.
No, avoid taking antacids within 30 minutes of taking this suspension, as they can interfere with the formation of the protective barrier.
The oxetacaine in the formulation provides rapid numbing relief from pain, often within minutes of consumption.
Constipation is a common side effect of sucralfate due to its aluminum content. Increasing fluid intake can help manage this.
Patients with severe kidney issues should consult a doctor, as the aluminum in sucralfate can accumulate in the body.
It is best to take other medications at least 2 hours before or after this suspension to ensure proper absorption.
Sucralfate with oxetacaine oral suspension is typically a prescription medication and should be taken under medical supervision.
Yes, RounTalk Pharma formulates PANRON 0 with a palatable flavor to ensure patient compliance and ease of use.
Store at room temperature away from direct sunlight and do not freeze the suspension.
Digestive health is the cornerstone of overall well-being. Chronic acidity and ulcers should not be ignored or treated with temporary fixes. Sucralfate with oxetacaine oral suspension offers a sophisticated, dual-action approach that addresses both the agonizing pain and the structural damage of the gastrointestinal lining.
Through PANRON 0, RounTalk Pharma provides a high-quality, reliable solution for those seeking relief from GERD, gastritis, and peptic ulcers. By combining the “bandage” effect of sucralfate with the rapid numbing power of oxetacaine, we ensure that patients can return to their daily lives without the constant shadow of stomach pain.
If you are suffering from persistent gastric distress, ask your healthcare provider about sucralfate with oxetacaine oral suspension. Trust PANRON 0 by RounTalk Pharma to be your partner in digestive recovery and long-term mucosal health.
Contact Details:
Address: ROUNTALK PHARMA, Kundli, New Shivpuri Colony, Sonipat-131028 (HR.) INDIA
Phone No: +91 9534251767 | +91-9204444056
Email: rountalkpharma@gmail.com
Website: rountalkpharma.in